Issue 32, 2021

Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior

Abstract

Axitinib (AXI) is an oral selective tyrosine kinase inhibitor used for the treatment of early to advanced renal cell carcinoma. However, the clinical efficacy of AXI is severely limited by low oral bioavailability due to its poor aqueous solubility. Although AXI was found to demonstrate six polymorphs, at least 66 solvates and some salts, cocrystals of AXI have not been reported up to the present. To improve its aqueous solubility, cocrystallization of AXI with a group of carboxylic acids was attempted in the present work. Finally, one salt cocrystal with fumaric acid and two molecular cocrystals with suberic acid and trans-cinnamic acid were successfully prepared by liquid assisted grinding and slurry methods. The newly obtained cocrystals were characterized by single crystal and powder X-ray diffraction, thermal analysis, proton nuclear magnetic resonance and Fourier transform infrared spectroscopy and were subjected to powder and intrinsic dissolution experiments, dynamic vapor sorption studies and stability tests. In comparison to pure AXI, all of the cocrystals show a significantly improved apparent solubility and dissolution rate without compromising the physical stability of the drug. These findings suggest that the cocrystals herein could be used as promising solid forms of AXI for the development of its more effective oral formulations.

Graphical abstract: Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior

Supplementary files

Article information

Article type
Paper
Submitted
08 Mud 2021
Accepted
09 Maw 2021
First published
13 Maw 2021

CrystEngComm, 2021,23, 5504-5515

Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior

B. Ren, X. Dai, J. Wang, C. Wu, T. Lu and J. Chen, CrystEngComm, 2021, 23, 5504 DOI: 10.1039/D1CE00620G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements